ENERGI-F703 GEL

· Energenesis Biomedical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ENERGI-F703 GEL, covering 2024-02-20 to 2025-10-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer [Phase 3]